Future expansion hinges on integrating digital connectivity with lab-quality sensitivity to solidify decentralized care.

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.